The fact that IMHC finished the first quarter of the year with $3,600 in cash, $8,600 total current assets and $6,085 in sales doesn’t inspire much confidence, either. The problem is that although those $6 thousand in sales that were generated by IMHC may seem rather underwhelming MAXD themselves were incapable of reaching even that amount. In fact, let's take a look at what they had in terms of financials as of March 31, 2016:
• $650 thousand cash
• $749 thousand total current assets
• $12.57 million total current liabilities
• ZERO revenues
• $7 million net loss
At least back in April MAXD announced that they had been able to repay $3.6 million in convertible notes. An impressive achievement, indeed, but whatever positive effects it might have had got erased almost immediately by the fact that the shareholders of the company had already been put through a severe amount of dilution.
During the first three months of the year MAXD issued 292 million shares as a conversion of debt and accrued interest and 12 million shares for services. In April another 78.9 million shares were issued a conversion of $192 thousand in debt. MAXD may have stated that they have paid-off all of the previous outstanding convertible notes but the lack of revenues makes it obvious that they will have to continue raising funds from outside sources. The subsequent events section of the report reveals exactly that - on April 6 MAXD sold a $171 thousand note convertible into shares at 35% discount which was followed two days later by an agreement to issue up to $2 million in a convertible note.
The company is still continuing its litigation against VSL while in a PR from February it stated its plans to appeal the court's decision regarding the company's litigation against Google. Is this enough to offset the myriad of red flags? Ultimately, it is up to you to decide.